These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21028660)

  • 21. [A case of arsical thrombocytopenic purpura treated with BAL].
    DE CORDOVA CASTRO A; PENALVER BALLINA R
    Bol Soc Cubana Dermatol Sifilogr; 1948 Mar; 5(1):13-7. PubMed ID: 18856541
    [No Abstract]   [Full Text] [Related]  

  • 22. 2,3 Dithiolpropanol ("BAL") as a specific detoxifying agent for arsenic.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    Fed Proc; 1946; 5(1 Pt 2):175. PubMed ID: 21064305
    [No Abstract]   [Full Text] [Related]  

  • 23. Poisoning from inhalation of the vapors of lewisite and phenyldichlorarsine; its pathology in the dog and treatment with 2,3-dimercaptopropanol (BAL).
    HARRISON HE; ORDWAY NK
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):76-80. PubMed ID: 20275116
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of BAL in the treatment of arsenical neuropathy.
    MALHOTRA SL
    Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288
    [No Abstract]   [Full Text] [Related]  

  • 25. Massive arsenic poisoning--effect of hemodialysis and dimercaprol on arsenic kinetics.
    Mathieu D; Mathieu-Nolf M; Germain-Alonso M; Neviere R; Furon D; Wattel F
    Intensive Care Med; 1992; 18(1):47-50. PubMed ID: 1578049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 27. Toxipathic hepatitis due to Fowler's solution; a case treated with dimercaprol.
    WADE HJ; FRAZER ES
    Lancet; 1953 Feb; 1(6754):269-71. PubMed ID: 13012048
    [No Abstract]   [Full Text] [Related]  

  • 28. British anti-Lewisite. III. Developments and applications.
    PETERS RA
    J R Inst Public Health; 1952 Jun; 15(6):151-67. PubMed ID: 14939268
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits.
    Inns RH; Rice P; Bright JE; Marrs TC
    Hum Exp Toxicol; 1990 Jul; 9(4):215-20. PubMed ID: 2167707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
    Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
    Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats.
    RIKER WF; ROSENFELD G
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):72-5. PubMed ID: 20275115
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of lewisite burns of the eye with BAL.
    HUGHES WF
    J Clin Invest; 1946 Jul; 25(4):541-8. PubMed ID: 21001628
    [No Abstract]   [Full Text] [Related]  

  • 33. British anti-Lewisite. II. Dithiols as antidotes.
    PETERS RA
    J R Inst Public Health; 1952 May; 15(5):122-39. PubMed ID: 14918251
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).
    CARLETON AB; PETERS RA
    J Clin Invest; 1946 Jul; 25(4):497-527. PubMed ID: 21001625
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute arsenic poisoning; treatment with BAL].
    IZAR G
    Minerva Med; 1950 Nov; 41(59):1021-3. PubMed ID: 14806195
    [No Abstract]   [Full Text] [Related]  

  • 36. Tryparsamide optic neuritis treated by 2,3 dimercaptopropanol (BAL).
    FRIEDENBERG S
    J Am Med Assoc; 1947 Dec; 135(16):1072. PubMed ID: 18897608
    [No Abstract]   [Full Text] [Related]  

  • 37. [Elimination of arsenic under the effects of penicillin, sodium thiomalate and BAL in chronic arsenic poisoning].
    DEGOS R; LORTAT-JACOB E; POULET J; LE BRETON R; REGNIER F
    Bull Soc Fr Dermatol Syphiligr; 1950; 57(3):281-3. PubMed ID: 14801577
    [No Abstract]   [Full Text] [Related]  

  • 38. British anti-lewisite; antidotal effects against therapeutic arsenicals.
    STOCKEN LA; THOMPSON RH; WHITTAKER VP
    Biochem J; 1947; 41(1):47-52. PubMed ID: 20287850
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacology of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning.
    Graziano JH; Cuccia D; Friedheim E
    J Pharmacol Exp Ther; 1978 Dec; 207(3):1051-5. PubMed ID: 215741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BAL in the treatment of arsenic poisoning.
    JEKEL LG
    Ariz Med; 1947 Sep; 4(5):46. PubMed ID: 20261175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.